Differential monocyte responses to TLR ligands in children with autism spectrum disorders

Brain, Behavior, and Immunity

Volumn 24, Issue 1, 2010, Pages 64-71

  Enstrom, Amanda M ^a   Onore, Charity E ^a   Van de Water, Judy A ^a   Ashwood, Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ASD; Autism; Cytokines; Inflammation; Monocytes; Toll like receptors

Indexed keywords

FLAGELLIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIGAND; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTISM; CELL CULTURE; CHILD; CLINICAL ARTICLE; COMMUNICATION DISORDER; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; MALE; MONOCYTE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; SUPERNATANT;

ANTIGENS, SURFACE; AUTISTIC DISORDER; CELL SEPARATION; CHILD, PRESCHOOL; CYTOKINES; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; LIGANDS; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; TOLL-LIKE RECEPTORS;

EID: 71749094505     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.08.001     Document Type: Article

References (67)

1. Aly H., Khashaba M.T., El-Ayouty M., El-Sayed O., and Hasanein B.M. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. 28 (2006) 178-182
2. Ashwood P., Schauer J., Pessah I.N., and Van de Water J. Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders. J. Neuroimmunol. 208 (2009) 130-135
3. Ashwood P., and Wakefield A.J. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 173 (2006) 126-134
4. Babcock A.A., Wirenfeldt M., Holm T., Nielsen H.H., Dissing-Olesen L., Toft-Hansen H., Millward J.M., Landmann R., Rivest S., Finsen B., and Owens T. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J. Neurosci. 26 (2006) 12826-12837
5. Beilmann M., Odenthal M., Jung W., Vande Woude G.F., Dienes H.P., and Schirmacher P. Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood 90 (1997) 4450-4458
6. Beilmann M., Vande Woude G.F., Dienes H.P., and Schirmacher P. Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood 95 (2000) 3964-3969
7. Borrell J., Vela J.M., Arevalo-Martin A., Molina-Holgado E., and Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26 (2002) 204-215
8. Bsibsi M., Ravid R., Gveric D., and van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61 (2002) 1013-1021
9. Cabanlit M., Wills S., Goines P., Ashwood P., and Van de Water J. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann. NY Acad. Sci. 1107 (2007) 92-103
10. Campbell D.B., D'Oronzio R., Garbett K., Ebert P.J., Mirnics K., Levitt P., and Persico A.M. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann. Neurol. 62 (2007) 243-250
11. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., Elia M., Schneider C., Melmed R., Sacco R., Persico A.M., and Levitt P. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. USA 103 (2006) 16834-16839
12. Connolly A.M., Chez M., Streif E.M., Keeling R.M., Golumbek P.T., Kwon J.M., Riviello J.J., Robinson R.G., Neuman R.J., and Deuel R.M. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry 59 (2006) 354-363
13. Connolly A.M., Chez M.G., Pestronk A., Arnold S.T., Mehta S., and Deuel R.K. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J. Pediatr. 134 (1999) 607-613
14. Croen L.A., Braunschweig D., Haapanen L., Yoshida C.K., Fireman B., Grether J.K., Kharrazi M., Hansen R.L., Ashwood P., and Van de Water J. Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol. Psychiatry 64 (2008) 583-588
15. Croonenberghs J., Bosmans E., Deboutte D., Kenis G., and Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 45 (2002) 1-6
16. Denney D.R., Frei B.W., and Gaffney G.R. Lymphocyte subsets and interleukin-2 receptors in autistic children. J. Autism Dev. Disord. 26 (1996) 87-97
17. Doherty G.H. Developmental switch in the effects of TNFalpha on ventral midbrain dopaminergic neurons. Neurosci. Res. 57 (2007) 296-305
18. Dunn A.J. Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res. 6 (2006) 52-68
19. Enstrom A., Krakowiak P., Onore C., Pessah I.N., Hertz-Picciotto I., Hansen R.L., Van de Water J.A., and Ashwood P. Increased IgG4 levels in children with autism disorder. Brain Behav. Immun. 23 (2009) 389-395
20. Enstrom A.M., Lit L., Onore C.E., Gregg J.P., Hansen R., Pessah I.N., Hertz-Picciotto I., Van de Water J.A., Sharp F.R., and Ashwood P. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav. Immun. 23 (2009) 124-133
21. Fleer A., and Krediet T.G. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn. Neonatology 92 (2007) 145-157
22. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J. Clin. Psychiatry 66 Suppl. 10 (2005) 3-8
23. Fortier M.E., Luheshi G.N., and Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav. Brain Res. 181 (2007) 270-277
24. Garbett K., Ebert P.J., Mitchell A., Lintas C., Manzi B., Mirnics K., and Persico A.M. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 30 (2008) 303-311
25. Gilmore J.H., Jarskog L.F., and Vadlamudi S. Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. J. Neuroimmunol. 159 (2005) 106-112
26. Gladkevich A., Kauffman H.F., and Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 559-576
27. Grigorenko E.L., Han S.S., Yrigollen C.M., Leng L., Mizue Y., Anderson G.M., Mulder E.J., de Bildt A., Minderaa R.B., Volkmar F.R., Chang J.T., and Bucala R. Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 122 (2008) e438-e445
28. Gupta S., Aggarwal S., Rashanravan B., and Lee T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J. Neuroimmunol. 85 (1998) 106-109
29. Hava G., Vered L., Yael M., Mordechai H., and Mahoud H. Alterations in behavior in adult offspring mice following maternal inflammation during pregnancy. Dev. Psychobiol. 48 (2006) 162-168
30. Hertz-Picciotto I., Croen L.A., Hansen R., Jones C.R., van de Water J., and Pessah I.N. The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ. Health Perspect. 114 (2006) 1119-1125
31. Hess D.C., Abe T., Hill W.D., Studdard A.M., Carothers J., Masuya M., Fleming P.A., Drake C.J., and Ogawa M. Hematopoietic origin of microglial and perivascular cells in brain. Exp. Neurol. 186 (2004) 134-144
32. Hoffmann O., Braun J.S., Becker D., Halle A., Freyer D., Dagand E., Lehnardt S., and Weber J.R. TLR2 mediates neuroinflammation and neuronal damage. J. Immunol. 178 (2007) 6476-6481
33. Ido A., Numata M., Kodama M., and Tsubouchi H. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J. Gastroenterol. 40 (2005) 925-931
34. Jyonouchi H., Geng L., Ruby A., and Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51 (2005) 77-85
35. Jyonouchi H., Sun S., and Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 46 (2002) 76-84
36. Jyonouchi H., Sun S., and Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 120 (2001) 170-179
37. Kawai T., and Akira S. TLR signaling. Semin. Immunol. 19 (2007) 24-32
38. Kielian T., Esen N., and Bearden E.D. Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia. Glia 49 (2005) 567-576
39. Kozlovskaia G.V., Kliushnik T.P., Goriunova A.V., Turkova I.L., Kalinina M.A., and Sergienko N.S. Nerve growth factor auto-antibodies in children with various forms of mental dysontogenesis and in schizophrenia high risk group. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 100 (2000) 50-52
40. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.-M., Ji L., Brown T., and Malik M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 207 (2009) 111-116
41. Mao T.K., Lian Z.X., Selmi C., Ichiki Y., Ashwood P., Ansari A.A., Coppel R.L., Shimoda S., Ishibashi H., and Gershwin M.E. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 42 (2005) 802-808
42. Meyer U., Nyffeler M., Schwendener S., Knuesel I., Yee B.K., and Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33 (2007) 441-456
43. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Courtney P., Altaye M., and Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J. Neuroimmunol. 172 (2006) 198-205
44. Odell D., Maciulis A., Cutler A., Warren L., McMahon W.M., Coon H., Stubbs G., Henley K., and Torres A. Confirmation of the association of the C4B null allele in autism. Hum. Immunol. 66 (2005) 140-145
45. Okunishi K., Dohi M., Nakagome K., Tanaka R., Mizuno S., Matsumoto K., Miyazaki J., Nakamura T., and Yamamoto K. A novel role of hepatocyte growth regulator through suppressing factor as an immune dendritic cell function. J. Immunol. 175 (2005) 4745-4753
46. Olson J.K., and Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173 (2004) 3916-3924
47. Persico A.M., D'Agruma L., Maiorano N., Totaro A., Militerni R., Bravaccio C., Wassink T.H., Schneider C., Melmed R., Trillo S., Montecchi F., Palermo M., Pascucci T., Puglisi-Allegra S., Reichelt K.L., Conciatori M., Marino R., Quattrocchi C.C., Baldi A., Zelante L., Gasparini P., and Keller F. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol. Psychiatry 6 (2001) 150-159
48. Rosen N.J., Yoshida C.K., and Croen L.A. Infection in the first 2 years of life and autism spectrum disorders. Pediatrics 119 (2007) 61-69
49. Rutella S., Bonanno G., Procoli A., Mariott A., de Ritis D.G., Curti A., Danese S., Pessina G., Pandolfi S., Natoni F., Di Febo A., Scambia G., Manfredini R., Salati S., Ferrari S., Pierelli L., Leone G., and Lemoli R.M. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12(low/neg) accessory cells with dendritic-cell features. Blood 108 (2006) 218-227
50. Rutter M., Bailey A., Berument S.K., Lord C., and Pickles A. Social Communication Questionnaire (SCQ) (2003), Western Psychological Services, Los Angeles
51. Samano E.S., Ribeiro Lde M., Gorescu R.G., Rocha K.C., and Grumach A.S. Involvement of C4 allotypes in the pathogenesis of human diseases. Rev. Hosp. Clin. Fac. Med. Sao Paulo 59 (2004) 138-144
52. Silva S.C., Correia C., Fesel C., Barreto M., Coutinho A.M., Marques C., Miguel T.S., Ataide A., Bento C., Borges L., Oliveira G., and Vicente A.M. Autoantibody repertoires to brain tissue in autism nuclear families. J. Neuroimmunol. 152 (2004) 176-182
53. Singh V.K., and Rivas W.H. Detection of antinuclear and antilaminin antibodies in autistic children who received thimerosal-containing vaccines. J. Biomed. Sci. 11 (2004) 607-610
54. Singh V.K., and Rivas W.H. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci. Lett. 355 (2004) 53-56
55. Singh V.K., Singh E.A., and Warren R.P. Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biol. Psychiatry 41 (1997) 753-755
56. Singh V.K., Warren R., Averett R., and Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 17 (1997) 88-90
57. Singh V.K., Warren R.P., Odell J.D., and Cole P. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin. Immunol. Immunopathol. 61 (1991) 448-455
58. Skaar D.A., Shao Y., Haines J.L., Stenger J.E., Jaworski J., Martin E.R., DeLong G.R., Moore J.H., McCauley J.L., Sutcliffe J.S., Ashley-Koch A.E., Cuccaro M.L., Folstein S.E., Gilbert J.R., and Pericak-Vance M.A. Analysis of the RELN gene as a genetic risk factor for autism. Mol. Psychiatry 10 (2005) 563-571
59. Smith S.E., Li J., Garbett K., Mirnics K., and Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 27 (2007) 10695-10702
60. Sweeten T.L., Posey D.J., and McDougle C.J. High blood monocyte counts and neopterin levels in children with autistic disorder. Am. J. Psychiatry 160 (2003) 1691-1693
61. Todd R.D., Hickok J.M., Anderson G.M., and Cohen D.J. Antibrain antibodies in infantile autism. Biol. Psychiatry 23 (1988) 644-647
62. Torres A.R., Maciulis A., and Odell D. The association of MHC genes with autism. Front. Biosci. 6 (2001) D936-D943
63. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57 (2005) 67-81
64. Warren R.P., Singh V.K., Averett R.E., Odell J.D., Maciulis A., Burger R.A., Daniels W.W., and Warren W.L. Immunogenetic studies in autism and related disorders. Mol. Chem. Neuropathol. 28 (1996) 77-81
65. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D., and Van de Water J. Autoantibodies in autism spectrum disorders (ASD). Ann. NY Acad. Sci. 1107 (2007) 79-91
66. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D.G., and Van de Water J. Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav. Immun. 23 (2009) 64-74
67. Zekki H., Feinstein D.L., and Rivest S. The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol. 12 (2002) 308-319